A Nevada judge postponed the execution of a convicted murderer with hours to spare on Wednesday after a pharmaceutical company filed suit to keep one of its drugs from being used in the lethal injection.
The postponement marks the first time that a pharmaceutical company has succeeded in halting a U.S. execution using a drug that it manufactures. New Jersey company Alvogen wants to prevent Nevada from using its sedative midazolam in a newly formulated lethal injection cocktail. The drug cocktail has never been tried in the U.S., and Alvogen does not want one of its products involved in a “botched” execution, reported the Associated Press.
Company - State - Midazolam - Subterfuge - Nevada
The pharmaceutical company claims the state obtained midazolam through “subterfuge,” although Nevada...